You have no items in your shopping cart.
Oncology
In this section you will find Therapeutics Diseases & Conditions Oncology market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
| Items 1 to 10 of 480 total | Page: | Show per page |
| View as: List Grid |
Sort by
|
Analytical Tool - Peptides in Oncology
Published by BioSeeker Group on Jun 24th, 2010
€ 3,100.00
A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer peptide R&D and business development. Learn More
Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline
Published by BioSeeker Group on Jun 24th, 2010
€ 2,450.00
This report identifies the competitive terrain for cancer therapeutic peptides to be wide open from a compound perspective and the opportunity for peptide drugs to challenge other biologicals such as antibodies is real and significant. Learn More
Triple Analysis: Breast Cancer, Colorectal Cancer and Leukemia
Published by BioSeeker Group on Jun 24th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Colorectal Cancer and by the compound strategy of Peptides. Learn More
Triple Analysis: Breast Cancer, Leukemia and Peptides
Published by BioSeeker Group on Jun 24th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Leukemia and by the compound strategy of Peptides. Learn More
Triple Analysis: Breast Cancer, Lung Cancer and Peptides
Published by BioSeeker Group on Jun 24th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the compound strategy of Peptides. Learn More
Triple Analysis: Breast Cancer, Lymphoma and Peptides
Published by BioSeeker Group on Jun 24th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lymphoma and by the compound strategy of Peptides. Learn More
Triple Analysis: Breast Cancer, Melanoma and Peptides
Published by BioSeeker Group on Jun 24th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the compound strategy of Peptides. Learn More
Triple Analysis: Breast Cancer, Pancreatic Cancer and Peptides
Published by BioSeeker Group on Jun 24th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Pancreatic Cancer and by the compound strategy of Peptides. Learn More
Triple Analysis: Breast Cancer, Prostate Cancer and Peptides
Published by BioSeeker Group on Jun 24th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the compound strategy of Peptides. Learn More
Triple Analysis: Breast Cancer, Apoptosis and Peptides
Published by BioSeeker Group on Jun 24th, 2010
€ 3,450.00
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). Learn More
| Items 1 to 10 of 480 total | Page: | Show per page |
| View as: List Grid |
Sort by
|